IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:IPN - FR0010259150 - Common Stock
119 EUR
0 (0%)
Overall IPN gets a fundamental rating of 6 out of 10. We evaluated IPN against 52 industry peers in the Pharmaceuticals industry. IPN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IPN may be a bit undervalued, certainly considering the very reasonable score on growth This makes IPN very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year IPN was profitable.
IPN had a positive operating cash flow in the past year.
IPN had positive earnings in each of the past 5 years.
Each year in the past 5 years IPN had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 6.56%, IPN perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
IPN's Return On Equity of 10.59% is in line compared to the rest of the industry. IPN outperforms 55.77% of its industry peers.
With a decent Return On Invested Capital value of 14.88%, IPN is doing good in the industry, outperforming 76.92% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IPN is in line with the industry average of 13.72%.
The last Return On Invested Capital (14.88%) for IPN is above the 3 year average (12.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
IPN has a Profit Margin (11.91%) which is in line with its industry peers.
In the last couple of years the Profit Margin of IPN has declined.
IPN has a Operating Margin of 26.01%. This is in the better half of the industry: IPN outperforms 65.38% of its industry peers.
IPN's Operating Margin has declined in the last couple of years.
The Gross Margin of IPN (83.32%) is better than 90.38% of its industry peers.
IPN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
IPN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
IPN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for IPN remains at a similar level compared to 5 years ago.
IPN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.43 indicates that IPN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.43, IPN is in the better half of the industry, outperforming 63.46% of the companies in the same industry.
IPN has a debt to FCF ratio of 1.69. This is a very positive value and a sign of high solvency as it would only need 1.69 years to pay back of all of its debts.
IPN's Debt to FCF ratio of 1.69 is amongst the best of the industry. IPN outperforms 88.46% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that IPN is not too dependend on debt financing.
IPN's Debt to Equity ratio of 0.20 is fine compared to the rest of the industry. IPN outperforms 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.43 |
ROIC/WACC1.91
WACC7.8%
2.3 Liquidity
IPN has a Current Ratio of 1.98. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
IPN has a Current ratio of 1.98. This is in the better half of the industry: IPN outperforms 69.23% of its industry peers.
A Quick Ratio of 1.80 indicates that IPN should not have too much problems paying its short term obligations.
The Quick ratio of IPN (1.80) is better than 78.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
The Earnings Per Share has been growing by 8.79% on average over the past years. This is quite good.
Looking at the last year, IPN shows a quite strong growth in Revenue. The Revenue has grown by 9.45% in the last year.
Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
IPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.58% yearly.
The Revenue is expected to grow by 4.58% on average over the next years.
EPS Next Y10.08%
EPS Next 2Y3.94%
EPS Next 3Y4.55%
EPS Next 5Y5.58%
Revenue Next Year8.8%
Revenue Next 2Y6.24%
Revenue Next 3Y6.01%
Revenue Next 5Y4.58%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.59, which indicates a very decent valuation of IPN.
Based on the Price/Earnings ratio, IPN is valued cheaper than 80.77% of the companies in the same industry.
When comparing the Price/Earnings ratio of IPN to the average of the S&P500 Index (26.51), we can say IPN is valued rather cheaply.
The Price/Forward Earnings ratio is 10.72, which indicates a very decent valuation of IPN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 78.85% of the companies listed in the same industry.
IPN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.13.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.59 | ||
| Fwd PE | 10.72 |
4.2 Price Multiples
96.15% of the companies in the same industry are more expensive than IPN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, IPN is valued a bit cheaper than 71.15% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.34 | ||
| EV/EBITDA | 5.61 |
4.3 Compensation for Growth
IPN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
IPN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.15
PEG (5Y)1.32
EPS Next 2Y3.94%
EPS Next 3Y4.55%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.17%, IPN has a reasonable but not impressive dividend return.
IPN's Dividend Yield is comparable with the industry average which is at 2.20.
Compared to an average S&P500 Dividend Yield of 2.00, IPN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.17% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
IPN pays out 25.90% of its income as dividend. This is a sustainable payout ratio.
IPN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP25.9%
EPS Next 2Y3.94%
EPS Next 3Y4.55%
EPA:IPN (12/31/2025, 7:00:00 PM)
119
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners15.21%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap9.97B
Revenue(TTM)3.76B
Net Income(TTM)447.90M
Analysts68.89
Price Target131.89 (10.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.17% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.59%
PT rev (3m)2.63%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.16%
EPS NY rev (3m)4.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.52%
Revenue NY rev (3m)1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.59 | ||
| Fwd PE | 10.72 | ||
| P/S | 2.65 | ||
| P/FCF | 19.34 | ||
| P/OCF | 11.12 | ||
| P/B | 2.36 | ||
| P/tB | 7.47 | ||
| EV/EBITDA | 5.61 |
EPS(TTM)10.27
EY8.63%
EPS(NY)11.1
Fwd EY9.32%
FCF(TTM)6.15
FCFY5.17%
OCF(TTM)10.71
OCFY9%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.15
PEG (5Y)1.32
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.43 |
F-Score7
WACC7.8%
ROIC/WACC1.91
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y10.08%
EPS Next 2Y3.94%
EPS Next 3Y4.55%
EPS Next 5Y5.58%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.8%
Revenue Next 2Y6.24%
Revenue Next 3Y6.01%
Revenue Next 5Y4.58%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year41.46%
EBIT Next 3Y13.73%
EBIT Next 5Y7.89%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
What is the valuation status of IPSEN (IPN.PA) stock?
ChartMill assigns a valuation rating of 7 / 10 to IPSEN (IPN.PA). This can be considered as Undervalued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the financial health of IPSEN (IPN.PA) stock?
The financial health rating of IPSEN (IPN.PA) is 7 / 10.
How sustainable is the dividend of IPSEN (IPN.PA) stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.9%.